Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Pharmion Corporation is, and any amendment thereto signed by each of the undersigned shall be, filed on...Joint Filing Agreement • February 8th, 2005 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Pharmion Corporation is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Dated: November 30, 2005 /s/ Pasquale DeAngelis ----------------------------------------- Pasquale DeAngelis, as a member of ProQuest Associates III LLC and on behalf of ProQuest Investments III, L.P., and as a member of ProQuest Associates II LLC and...Joint Filing Agreement • February 13th, 2006 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Cytogen Corp. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • May 24th, 2006 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that statements on Schedules 13G and 13D and Forms 3, 4 and 5 with respect to the shares of common stock of Novacea, Inc. and any amendments thereto signed by each of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement may be included as an exhibit to such statements or amendments. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2006 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Threshold Pharmaceuticals, Inc. is, and any amendment thereto (collectively, the "Schedule 13G") signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2007 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of NovaDel Pharma Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
NOTE AND WARRANT AMENDMENT AGREEMENTNote and Warrant Amendment Agreement • January 5th, 2010 • Proquest Investments Ii Lp • Pharmaceutical preparations • New York
This NOTE AND WARRANT AMENDMENT AGREEMENT (this “Amendment”), dated as of December 31, 2009, by and among NovaDel Pharma Inc., a Delaware corporation (the “Company”), and ProQuest Investment II, L.P., ProQuest Investment Advisors Fund II, L.P. and ProQuest Investments III, L.P. (the “Holders”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2007 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock of Threshold Pharmaceuticals, Inc. is, and any amendment thereto (collectively, the “Schedule 13G”) signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2007 • Proquest Investments Ii Lp • Pharmaceutical preparations
This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2008 • Proquest Investments Ii Lp • Pharmaceutical preparations
This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • December 23rd, 2008 • Proquest Investments Ii Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13D with respect to the shares of common stock of NovaDel Pharma Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended. The undersigned hereby further agree that this Joint Filing Agreement be included as an exhibit to such statement and any such amendment. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
